Compare SCVL & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCVL | BBNX |
|---|---|---|
| Founded | 1978 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.1M | 493.1M |
| IPO Year | 1994 | N/A |
| Metric | SCVL | BBNX |
|---|---|---|
| Price | $15.87 | $10.03 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | N/A | ★ $26.22 |
| AVG Volume (30 Days) | 389.6K | ★ 957.7K |
| Earning Date | 03-26-2026 | 04-21-2026 |
| Dividend Yield | ★ 4.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $1,135,324,000.00 | N/A |
| Revenue This Year | $0.76 | $34.99 |
| Revenue Next Year | $2.53 | $34.47 |
| P/E Ratio | $8.42 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.04 | $9.37 |
| 52 Week High | $26.54 | $32.71 |
| Indicator | SCVL | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 32.73 | 33.74 |
| Support Level | $15.21 | $9.91 |
| Resistance Level | $18.37 | $11.92 |
| Average True Range (ATR) | 0.72 | 0.66 |
| MACD | -0.12 | 0.10 |
| Stochastic Oscillator | 25.37 | 26.27 |
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.